Please provide your email address to receive an email when new articles are posted on . Among patients with peripheral artery disease, the use of vorapaxar appears to reduce peripheral ...

October 9, 2009 (Vienna, Austria) — A reduction in major amputations associated with diabetic foot followed the increased rates of peripheral revascularization that occurred after implementation of ...

Both the incidence and degree of bleeding events after peripheral revascularization match what’s seen for coronary revascularization and for lower-extremity amputation, new findings from the EUCLID ...

Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...

In the Losartan Intervention For End point reduction in hypertension (LIFE) study losartan- compared to atenolol-based antihypertensive treatment showed a tendency towards reducing peripheral ...

June 28, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a new version of a peripheral revascularization catheter (Jetstream G3 Small Fixed [SF]; Pathway Medical ...

People who took rivaroxaban (Xarelto) after lower-extremity revascularization for peripheral artery disease (PAD) enjoyed fewer subsequent major adverse limb and cardiovascular events, according to ...

BOSTON - Peripheral arterial disease (PAD), a vascular condition that prevents blood flow to the extremities, currently affects 8.5 million people in the United States. A study of nearly 62,000 ...

"Our findings highlight the clinical importance of focusing on total disease burden, rather than first events, and the need for long-term preventive strategies in high-risk patients."—Michael Szarek, ...

Lower extremity artery disease (LEAD) is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people. On top of that, LEAD also represents a prominent marker of ...

Compared with white patients, Black patients with PAD who undergo peripheral revascularization have much more advanced disease at the time of their procedures and are less likely to receive necessary ...